Association of differential expression of immunoregulatory molecules and presence of targetable mutations may inform rational design of clinical trials
- Resource Type
- Article
- Source
- In
ESMO Open February 2022 7(1) - Subject
Onco-Immunology - Language
- ISSN
- 2059-7029